Hackensack Meridian Health Mountainside, also known as Mountainside Hospital, is an acute-care hospital located in Montclair, New Jersey, United States. The hospital has 396 beds and serves Northeastern Essex County.

There are 231 beds in Mountainside Hospital Cancer Center.

During the past decade, Mountainside Hospital Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountainside Hospital Cancer Center" #1 sponsor was "University of Medicine and Dentistry of New Jersey" with 3 trials, followed by "Eastern Cooperative Oncology Group" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountainside Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Aventis Pharmaceuticals" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mountainside Hospital Cancer Center" are "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Anal Cancer" (1 trials), "Bladder Cancer" (1 trials) and "Carcinoma of Unknown Primary" (1 trials). Many other conditions were trialed in "Mountainside Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Mountainside Hospital Cancer Center" are "Drug" (9 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (3 trials), "radiation therapy" (3 trials), "carboplatin" (2 trials), "cisplatin" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mountainside Hospital Cancer Center" are 7 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mountainside Hospital Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mountainside Hospital Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mountainside Hospital Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".